Research Frontiers Incorporated (REFR) Financial Statements (2025 and earlier)

Company Profile

Business Address 240 CROSSWAYS PARK DR
WOODBURY, NY 11797-2033
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 6794 - Patent Owners and Lessors (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,9941,6481,9072,0932,4763,000
Cash and cash equivalent1,9941,6481,9072,0932,476525
Short-term investments      2,500
Other undisclosed cash, cash equivalents, and short-term investments      (25)
Receivables7011,0861,1119851,003846
Other undisclosed current assets511171722139764
Total current assets:2,7462,8513,1903,2913,5763,910
Noncurrent Assets
Operating lease, right-of-use asset1,22371107143179214
Property, plant and equipment152127334046
Other noncurrent assets565656565656
Total noncurrent assets:1,294148190232274317
TOTAL ASSETS:4,0402,9993,3803,5233,8514,227
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities139661012236553
Accounts payable8634611715132
Accrued liabilities533240511421
Deferred revenue   125   
Other undisclosed current liabilities130110164217212212
Total current liabilities:269176390439277264
Noncurrent Liabilities
Liabilities, other than long-term debt1,166   55110
Operating lease, liability1,166   55110
Total noncurrent liabilities:1,166   55110
Total liabilities:1,435176390439333374
Equity
Equity, attributable to parent2,6042,8232,9903,0843,5183,853
Common stock333333
Additional paid in capital128,177127,788127,788127,788127,779127,634
Accumulated deficit(125,576)(124,968)(124,801)(124,707)(124,265)(123,785)
Total equity:2,6042,8232,9903,0843,5183,853
TOTAL LIABILITIES AND EQUITY:4,0402,9993,3803,5233,8514,227

Income Statement (P&L) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Revenues178354490313312164
Gross profit:178354490313312164
Operating expenses(802)(586)(606)(783)(818)(678)
Operating loss:(624)(232)(116)(470)(505)(514)
Nonoperating income
(Investment Income, Nonoperating)
163022272542
Net loss:(608)(202)(94)(443)(480)(472)
Other undisclosed net income attributable to parent 35    
Net loss available to common stockholders, diluted:(608)(167)(94)(443)(480)(472)

Comprehensive Income ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Net loss:(608)(202)(94)(443)(480)(472)
Comprehensive loss, net of tax, attributable to parent:(608)(202)(94)(443)(480)(472)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: